As medical providers we have a goal of reducing pain and suffering. To achieve that goal we use opioid analgesics, non-opioid Analgesics, and other modalities. This program will discuss the indications, contraindications, benefits, and risks of various forms of analgesia.
This activity is intended for providers who manage patient pain
Learning Objectives: At the end of the educational program, the learner will be able to:
Dr Brody has been in practice since 1988 and has served as a Residency Director at DVAMC Northport. He has held staff appointments at a number of Colleges of Podiatry and lectures around the country on compliance for medical doctors and staff.
Dr. Jacobs is a 1973 Summa Cum Laude graduate of the Pennsylvania College of Podiatric Medicine. He completed his residency in surgery at Monsignor Clement Kern Hospital for special surgery in Warren, Michigan in 1975. Dr. Jacobs is in private practice in St. Louis, Missouri. He is board certified in reconstructive surgery of the foot and ankle by the American Board of Podiatric Surgery, and is a Fellow of the American College of Foot and Ankle Surgeons. For 25 years, Dr. Jacobs served as a Director of Podiatric Surgical Residency Training; and has also served as a contributing editor to the Journal of Foot Surgery, Podiatry Today, Foot and Ankle Quarterly and Clinics in Podiatric Medicine and Surgery. Additionally, Dr. Jacobs has served as the Scientific Chairman of the American Podiatric Medical Association, The Missouri Podiatry Society, and on the Journal Management Committee of the American College of Foot and Ankle Surgery. He was the first podiatrist to receive the rank of Fellow by Temple University. He was voted a Lifetime Achievement Award and to The Podiatry Hall of Fame. He has received numerous awards from the APMA and ACFAS for his dedication to podiatry and podiatric education, as well as recognition from the governors of Missouri, Arkansas and Massachusetts. He has published over 80 scientific articles in various publications and 17 chapter contributions in various textbooks, and has presented over 1000 papers at podiatric and medical society meetings. In addition to his practice, Dr. Jacobs maintains a free educational website, www.centerforpodiatriceducation.com, with open access to students, residents and practitioners of podiatric medicine and surgery. He is a nationally recognized author, researcher and a noted authority of surgery of the foot.
Luke D. Cicchinelli, DPM FACFAS is the Chief Medical Director for PICA. He is a 1990 graduate of Temple University School of Podiatric Medicine and a 1993 graduate and has been a faculty member of The Podiatry Institute in Atlanta, Georgia. He practiced for 19 years in the USA between North Carolina and Arizona and 3 years between Australia and Spain focusing primarily on reconstructive surgery and sports medicine of the foot and ankle and teaching.
Matthew S. Feldman is a member of Feldman Kiefer, LLP’s. He represents business entities, including health care professionals and institutions, in legal matters. Mr. Feldman also concentrates his practice in professional liability matters before the Department of Health’s Office of Professional Medical Conduct.
Dr. Lawhern is a non-clinician subject matter expert on US and Canadian public health policy for regulation of prescription opioid pain relievers and of clinicians who employ opioids in managing severe pain for patients. He is a healthcare writer and moderator for online peer-to-peer patient support groups.
Dr. Wasser is an internist practicing in addiction medicine in Rockville Centre Long Island. He is board certified in addiction medicine by the American Board of Preventive Medicine and the American board of Addiction medicine and practices in both office and clinic-based settings while also doing liaison addiction medicine consultation at Mount Sinai-South Nassau hospital.
Registration $89
Free for those that attended the live event
Intended Audience : Medical Providers
No refunds are available for online courses
In accordance with the Council on Podiatric Medical Education's Standards and Requirements for Approval of Providers of Continuing Education in Podiatric Medicine, any relevant financial relationships with commercial interests of faculty, planning committee, or any others who have influence over the content of this educational activity must be disclosed to program participants.
CME Online is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. CME Online has approved this activity for a maximum of 8 continuing education contact hours.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and CME ONline. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
Steward Wasser, MD: Speakers Bureau: Indorsia
Luke Cicchinelli, DPM: Consultant: Arthrex, Ossio Employee: PICA
Michael Brody, DPM Matthew Feldman, JD Allen Jacobs, DPM Richard Lawhern, PhD
ACHL staff members, CME ONline staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of any publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.